Literature DB >> 30828001

Convergent Synthesis of trans-2,6-Disubstituted Piperidine Alkaloid, (-)-iso-6-Spectaline by Palladium-Catalyzed Cyclization.

Risako Kameda1, Takuto Sohma1, Kazuya Kobayashi1, Ryosuke Uchiyama2, Kazuto Nosaka2, Hiroyuki Konno3, Kenichi Akaji1, Yasunao Hattori4.   

Abstract

The plant alkaloids, iso-6-spectaline and spectaline, isolated from the Cassia or Senna genera contain a characteristic 2,6-disubstituted piperidin-3-ol scaffold. Although both natural products are reported to exhibit a variety of interesting biological activities, few stereo-selective schemes for the construction of the 2,6-disubstituted scaffold have been reported. Following our previous studies regarding the synthesis of (+)-spectaline, herein we report the first convergent synthesis of (-)-iso-6-spectaline using a cross-metathesis under thermal conditions where the cis-2,6-disubstituted piperidin-3-ol scaffold is condensed with a long alkyl chain containing a terminal olefin. The cis-2,6-disubstituted piperidin-3-ol used in the synthesis was prepared simply via Pd(II)-catalyzed diastereoselective cyclization. It was confirmed that (+)-spectaline, an epimer of (-)-iso-6-spectaline, was selectively synthesized by the cross-metathesis reaction under less intense thermal conditions starting from the same cis-2,6-disubstituted piperidin-3-ol derivative.

Entities:  

Keywords:  Pd(II)-catalyzed cyclization; alkaloid; convergent synthesis; iso-6-spectaline; spectaline

Mesh:

Substances:

Year:  2019        PMID: 30828001     DOI: 10.1248/cpb.c18-00817

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Bark extract of Cassia sieberiana DC. (Caesalpiniaceae) displayed good antibacterial activity against MDR gram-negative phenotypes in the presence of phenylalanine-arginine β-naphthylamide.

Authors:  Marilene M M Ambadiang; Brice C K Atontsa; Simplice B Tankeo; Paul Nayim; Brice E N Wamba; Gabin T M Bitchagno; James D S Mpetga; Veronique B Penlap; Victor Kuete
Journal:  BMC Complement Med Ther       Date:  2020-11-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.